⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Wr-1065 SCHEMBL21750087 | 0.97 | ESR1 (0.94) | — | |
| Wr-1065 SCHEMBL4640384 | 0.97 | ESR1 (0.94) | — | |
| SCHEMBL28279929 | 0.95 | ESR1 (0.90) | — | |
| SCHEMBL26150367 | 0.92 | — | — | |
| SCHEMBL17119217 | 0.88 | ESR1 (0.79) | — | |
| SCHEMBL7513011 | 0.88 | — | — | |
| SCHEMBL7757906 | 0.88 | — | — | |
| Wr-1065 SCHEMBL1821959 | 0.86 | ESR1 (0.74) | — | |
| SCHEMBL11228775 | 0.85 | ESR1 (0.74) | — | |
| SCHEMBL7524242 | 0.85 | ESR1 (0.74) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673532-A1 | THERAPY | Plasticell Limited (GB) | 2026-01-07 | — | — | EP | claimed |
| US-20250222142-A1 | METAL COMPOSITE FOR ULTRASONIC CONTRAST AND USE THEREOF | ORIGINAL BIOMEDICALS CO., LTD. (TW) | 2025-07-10 | — | — | US | claimed |
| WO-2025075691-A1 | IRRADIATION PROTECTION METHODS USES AND COMPOSITIONS | XERIENT PHARMA LTD. (IL) | 2025-04-10 | — | — | WO | claimed |
| US-12263144-B2 | Methods of treating IgA nephropathy with thiol-containing molecules | Accubit LLC—Biotechnology (US) | 2025-04-01 | — | — | US | claimed |
| WO-2025048777-A1 | TRACEABLE ORAL FORMULATIONS AND USES THEREOF | The IP Law Firm of Guy Levi, LLC (US) | 2025-03-06 | — | — | WO | claimed |
| WO-2025003387-A1 | METHODS FOR TREATING RADIOACTIVE CONTAMINATION | MEXBRAIN (FR) | 2025-01-02 | — | — | WO | claimed |
| WO-2024211590-A1 | PHARMACEUTICALLY ACTIVE COMPOSITIONS AND USES THEREOF | XERIENT PHARMA LTD. (IL) | 2024-10-10 | — | — | WO | claimed |
| WO-2024180345-A1 | THERAPY | PLASTICELL LTD (GB) | 2024-09-06 | — | — | WO | claimed |
| EP-4393517-A1 | METAL COMPOSITE FOR ULTRASONIC CONTRAST AND USE THEREOF | Original Biomedicals Co., Ltd. (TW) | 2024-07-03 | — | — | EP | claimed |
| CN-118019552-A | Metal complexes for ultrasound imaging and use thereof | 原创生医股份有限公司 | 2024-05-10 | — | — | CN | claimed |
| WO-2001035999-A1 | STABLE AMORPHOUS AMIFOSTINE COMPOSITION, AND PREPARATION THEREOF | MEDIMMUNE ONCOLOGY, INC. (US) | 2001-05-25 | — | — | WO | claimed |
| US-6218377-B1 | ADMINISTERING AMINO THIOL COMPOUND OR AMINO PHOSPHOROTHIOATE COMPOUND FOR THERAPY AND PROTECTING AGAINST SIDE EFFECT OF CHEMOTHERAPY DRUGS SUCH AS ALKYLATING AGENTS, PLATINUM AGENTS, ANTHRACYCLINES, TAXANES, AND THEIR MIXTURES | MEDIMMUNE ONCOLOGY INC. | 2001-04-17 | — | — | US | claimed |
| US-6127351-A | FOR TREATING OR PROTECTING A SUBJECT AGAINST THE TOXICITIES ASSOCIATED WITH CANCER CHEMOTHERAPY, SIDE EFFECT REDUCTION | MEDIMMUNE ONCOLOGY INC. (US) | 2000-10-03 | — | — | US | claimed |
| WO-2000029025-A1 | STABLE AMORPHOUS AMIFOSTINE COMPOSITIONS AND METHODS FOR THE PREPARATION AND USE OF SAME | U.S. BIOSCIENCE, INC. (US) | 2000-05-25 | — | — | WO | claimed |
| US-5869338-A | Method for protection against genotoxic mutagenesis | ARCH DEVELOPMENT CORPORATION (US) | 1999-02-09 | — | — | US | claimed |
| EP-0764027-A4 | METHOD FOR PROTECTION AGAINST GENOTOXIC MUTAGENESIS | ARCH DEV CORP (US) | 1998-04-22 | — | — | EP | claimed |
| EP-0764027-A1 | METHOD FOR PROTECTION AGAINST GENOTOXIC MUTAGENESIS | ARCH DEVELOPMENT CORPORATION (US) | 1997-03-26 | — | — | EP | claimed |
| US-5591731-A | Crystalline amifostine compositions | U.S. BIOSCIENCE, INC. (US) | 1997-01-07 | — | — | US | claimed |
| WO-1995007700-A1 | METHOD FOR PROTECTION AGAINST GENOTOXIC MUTAGENESIS | ARCH DEVELOPMENT CORPORATION (US) | 1995-03-23 | — | — | WO | claimed |
| WO-1993017689-A1 | METHOD FOR PROTECTION AGAINST GENOTOXIC MUTAGENESIS | ARCH DEVELOPMENT CORPORATION (US) | 1993-09-16 | — | — | WO | claimed |